Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Withdrawn 1Unknown 1Terminated 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

fludarabine phosphate 2Psychiatric Rehabilitation 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Mycophenolic Acid 2Methylprednisolone 2Lenalidomide 2Cyclosporine 2Antilymphocyte Serum 2tazarotenic acid 1tazarotene 1sintilimab 1romidepsin 1motesanib diphosphate 1mogamulizumab 1carbendazim 1Valproic Acid 1VAP-cyclo protocol 1Ultraviolet Therapy 1Therapeutics 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Methoxsalen 1Methotrexate 1Melphalan 1Levofloxacin 1Leucovorin 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, T-Cell, Cutaneous × Bexarotene × Clear all
NCT00030589 2013-12-18

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡